Filters
Results: 1 to 18 of 18
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
SNAP25 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Congenital Myasthenic Syndrome Panel PreventionGenetics, part of Exact Sciences United States | 59 | 32 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 480 | 254 |
|
Genetic Services Laboratory University of Chicago United States | 289 | 481 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 466 | 297 |
|
Comprehensive Epilepsy Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 234 | 240 |
|
Epileptic encephalopathy panel. 128-gene NGS panel. Genologica Medica Spain | 197 | 128 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Congenital Myasthenic Syndromes (NGS Panel and Copy Number Analysis) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 26 | 22 |
|
Myasthenic syndrome, congenital: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 31 | 25 |
|
Epilepsy Advanced Sequencing and CNV Evaluation - Intellectual Disability Athena Diagnostics United States | 57 | 56 |
|
Epilepsy Advanced Sequencing and CNV Evaluation Athena Diagnostics United States | 233 | 234 |
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 143 | 135 |
|
Results: 1 to 18 of 18
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.